178 related articles for article (PubMed ID: 38596203)
1. Promising Intestinal Microbiota Associated with Clinical Characteristics of COPD Through Integrated Bioinformatics Analysis.
Lai T; Luo C; Yuan Y; Fang J; Wang Y; Tang X; Ouyang L; Lin K; Wu B; Yao W; Huang R
Int J Chron Obstruct Pulmon Dis; 2024; 19():873-886. PubMed ID: 38596203
[TBL] [Abstract][Full Text] [Related]
2. The treatment of Qibai Pingfei Capsule on chronic obstructive pulmonary disease may be mediated by Th17/Treg balance and gut-lung axis microbiota.
Jia Y; He T; Wu D; Tong J; Zhu J; Li Z; Dong J
J Transl Med; 2022 Jun; 20(1):281. PubMed ID: 35729584
[TBL] [Abstract][Full Text] [Related]
3. The alterations of oral, airway and intestine microbiota in chronic obstructive pulmonary disease: a systematic review and meta-analysis.
Kou Z; Liu K; Qiao Z; Wang Y; Li Y; Li Y; Yu X; Han W
Front Immunol; 2024; 15():1407439. PubMed ID: 38779669
[TBL] [Abstract][Full Text] [Related]
4. Gut microbiota dysbiosis contributes to the development of chronic obstructive pulmonary disease.
Li N; Dai Z; Wang Z; Deng Z; Zhang J; Pu J; Cao W; Pan T; Zhou Y; Yang Z; Li J; Li B; Ran P
Respir Res; 2021 Oct; 22(1):274. PubMed ID: 34696775
[TBL] [Abstract][Full Text] [Related]
5. Lung microbiome composition and bronchial epithelial gene expression in patients with COPD versus healthy individuals: a bacterial 16S rRNA gene sequencing and host transcriptomic analysis.
Ramsheh MY; Haldar K; Esteve-Codina A; Purser LF; Richardson M; Müller-Quernheim J; Greulich T; Nowinski A; Barta I; Stendardo M; Boschetto P; Korzybski D; Prasse A; Parr DG; Hohlfeld JM; Döme B; Welte T; Heath S; Gut I; Morrissey JA; Ziegler-Heitbrock L; Barer MR; Singh D; Brightling CE
Lancet Microbe; 2021 Jul; 2(7):e300-e310. PubMed ID: 35544166
[TBL] [Abstract][Full Text] [Related]
6. Variations in fecal microbial profiles of acute exacerbations and stable chronic obstructive pulmonary disease.
Wu Y; Luo Z; Liu C
Life Sci; 2021 Jan; 265():118738. PubMed ID: 33181175
[TBL] [Abstract][Full Text] [Related]
7. Characteristics and Clinical Significance of Intestinal Microbiota in Patients with Chronic Hepatitis B Cirrhosis and Type 2 Diabetes Mellitus.
Sun X; Chi X; Zhao Y; Liu S; Xing H
J Diabetes Res; 2022; 2022():1826181. PubMed ID: 35601017
[TBL] [Abstract][Full Text] [Related]
8. Links Between Inflammatory Bowel Disease and Chronic Obstructive Pulmonary Disease.
Raftery AL; Tsantikos E; Harris NL; Hibbs ML
Front Immunol; 2020; 11():2144. PubMed ID: 33042125
[TBL] [Abstract][Full Text] [Related]
9. [Changes of gut microflora in newly diagnosed IgA nephropathy patients and its correlation with clinical risk factors].
Bao WH; Tang W
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Feb; 55(1):124-132. PubMed ID: 36718700
[TBL] [Abstract][Full Text] [Related]
10. [Comparison Study of Oropharyngeal Microbiota in Case of Bronchial Asthma and Chronic Obstructive Pulmonary Disease in Different Severity Levels].
Ogorodova LM; Fedosenko SV; Popenko AS; Petrov VA; Tyakht AV; Saltykova IV; Deev IA; Kulikov ES; Kirillova NA; Govorun VM; Kostryukova ES
Vestn Ross Akad Med Nauk; 2015; (6):669-78. PubMed ID: 27093794
[TBL] [Abstract][Full Text] [Related]
11. The Intestinal Microbiota Composition in Early and Late Stages of Diabetic Kidney Disease.
Zhang L; Lu QY; Wu H; Cheng YL; Kang J; Xu ZG
Microbiol Spectr; 2023 Aug; 11(4):e0038223. PubMed ID: 37341590
[TBL] [Abstract][Full Text] [Related]
12. Analysis of sputum microbial flora in chronic obstructive pulmonary disease patients with different phenotypes during acute exacerbations.
Mao X; Li Y; Shi P; Zhu Z; Sun J; Xue Y; Wan Z; Yang D; Ma T; Wang J; Zhu R
Microb Pathog; 2023 Nov; 184():106335. PubMed ID: 37673353
[TBL] [Abstract][Full Text] [Related]
13. Changes in intestinal microbiota and correlation with TLRs in ulcerative colitis in the coastal area of northern China.
Xu N; Bai X; Cao X; Yue W; Jiang W; Yu Z
Microb Pathog; 2021 Jan; 150():104707. PubMed ID: 33352216
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive profiling of the gut microbiota in patients with chronic obstructive pulmonary disease of varying severity.
Chiu YC; Lee SW; Liu CW; Lin RC; Huang YC; Lan TY; Wu LS
PLoS One; 2021; 16(4):e0249944. PubMed ID: 33836012
[TBL] [Abstract][Full Text] [Related]
15. Gut microbiota modulates COPD pathogenesis: role of anti-inflammatory
Lai HC; Lin TL; Chen TW; Kuo YL; Chang CJ; Wu TR; Shu CC; Tsai YH; Swift S; Lu CC
Gut; 2022 Feb; 71(2):309-321. PubMed ID: 33687943
[TBL] [Abstract][Full Text] [Related]
16. Gut microbiota in children with juvenile idiopathic arthritis: characteristics, biomarker identification, and usefulness in clinical prediction.
Qian X; Liu YX; Ye X; Zheng W; Lv S; Mo M; Lin J; Wang W; Wang W; Zhang X; Lu M
BMC Genomics; 2020 Apr; 21(1):286. PubMed ID: 32264859
[TBL] [Abstract][Full Text] [Related]
17. Changes of intestinal bacterial microbiota in coronary heart disease complicated with nonalcoholic fatty liver disease.
Zhang Y; Xu J; Wang X; Ren X; Liu Y
BMC Genomics; 2019 Nov; 20(1):862. PubMed ID: 31726978
[TBL] [Abstract][Full Text] [Related]
18. Relationship between gut microbiota and lung function decline in patients with chronic obstructive pulmonary disease: a 1-year follow-up study.
Chiu YC; Lee SW; Liu CW; Lan TY; Wu LS
Respir Res; 2022 Jan; 23(1):10. PubMed ID: 35033061
[TBL] [Abstract][Full Text] [Related]
19. Using 16S rDNA and metagenomic sequencing technology to analyze the fecal microbiome of children with avoidant/restrictive food intake disorder.
Ye Q; Sun S; Deng J; Chen X; Zhang J; Lin S; Du H; Gao J; Zou X; Lin X; Cai Y; Lu Z
Sci Rep; 2023 Nov; 13(1):20253. PubMed ID: 37985845
[TBL] [Abstract][Full Text] [Related]
20. Alterations in the gut microbiota of AIDS patients with pneumocystis pneumonia and correlations with the lung microbiota.
Zhu M; Liu S; Zhao C; Shi J; Li C; Ling S; Cheng J; Dong W; Xu J
Front Cell Infect Microbiol; 2022; 12():1033427. PubMed ID: 36339339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
